Centre for Commercialization of Regenerative Medicine (CCRM)

The Centre for Commercialization of Regenerative Medicine (CCRM) provides strategic funding, dedicated infrastructure, and specialised business and scientific knowledge to enable the commercialization of regenerative medicine technologies, as well as cell and gene treatments.

The Canadian federal government, the province of Ontario, and top academic and business partners all contribute to the funding of CCRM, a global public-private collaboration with its headquarters in Canada. With an emphasis on cell and gene therapy, it promotes the development of regenerative drugs and related enabling technologies. A facility for cell and viral vector production that complies with good manufacturing practices is part of CCRM's 40,000 square foot advanced cell manufacturing facility. Through CCRM, the development of new businesses and patient-marketable products is sped up. The thriving biotech sector in Toronto is greatly influenced by CCRM.

With specialized teams, finance, and infrastructure, CCRM—a network of researchers, top businesses, strategic investors, and entrepreneurs—accelerates the conversion of scientific discoveries into new businesses and sellable goods for patients. The Ontario Institute for Regenerative Medicine and Medicine by Design at the University of Toronto collaborates with CCRM on commercialization.

Founded: 2011

Headquarters: Toronto, Canada

Website: https://www.ccrm.ca/